who medicines strategy - libdoc.who.int - World Health Organization
who medicines strategy - libdoc.who.int - World Health Organization who medicines strategy - libdoc.who.int - World Health Organization
WHO MEDICINES STRATEGY 2004-2007 | 80EO 4.5Public-interest NGOs includedin medicine supply strategies, insupport of national medicine supplystrategies to reach remote areasRationalePublic-interest NGOs and faith-basedorganizations often work in areas where theprivate for-profit health sector does not haveincentives to exist. These organizations playan important role in meeting the overall healthneeds and medicine requirements of theserural and often disadvantaged populations.WHO, in collaboration with the EcumenicalPharmaceutical Network based in Nairobi, Kenya,has undertaken a study in 10 sub-Saharan Africancountries on medicines supply and distributionactivities by faith-based organizations. Preliminaryfindings indicate that these organizations supportthe overall public health sector by covering 40%of the population and support around 80% ofhealth facilities, in mainly rural areas.WHO already works in collaboration with manypublic-interest NGOs, is involved in trainingcourses for NGO personnel, and has publishedpapers on NGO contributions. Another exampleis the close collaboration with Médecins SansFrontières (MSF) in the production of a jointreport about MSF’s experiences in procuring andsupplying ARVs in 10 countries where it operatesHIV/AIDS treatment programmes 41 . WHO alsoworks with international non-profit suppliers oflow-cost essential medicines, in particular on thecomposition and distribution of the WHO NewEmergency Health Kit, and through the GreenLight Committee for the supply of medicines formultidrug-resistant TB.As a result, faith-based organizations such asthose in the African Region have substantialexperience in the successful management ofmedicine supplies, mostly through a pooledpurchase mechanism (e.g. Ghana, Nigeria,Malawi, Zambia, Kenya, and Uganda). Inmost cases, they operate efficiently, havewell-motivated staff, and have adopted soundmanagement principles, including accountability.Although their skills, experience, andachievements are not always recognized or usedby national governments, some governmentsdo acknowledge the contribution of theseorganizations and collaborate with them to jointlysupply and distribute medicines supplies in thepublic health sector. The Joint Medical Stores inUganda and Mission of Essential Medicines andSupplies in Kenya are good examples of this kindof collaboration.
COMPONENTS OF THE STRATEGY | 81Meeting the challenges 2004-2007Over the next four years WHO will:> work with public-interest NGOs, faith-basedorganizations, and countries to support theassessment of best practices within NGOs andfaith-based organizations for incorporationinto national medicines supply policies andstrategies.Challenges remainingMany governments do not fully recognize oracknowledge the important contribution thatNGOs and faith-based organizations could makeand are already making in the equitable deliveryof basic health care. Many good examples ofcost-effective drug supply management by NGOsand faith-based organizations are ignored and notused to their full potential as examples for publicservices.> support the NGOs and faith-basedorganizations by offering them a full shareof available technical information, policyguidance, and training opportunities.> continue to promote the use of all availablechannels, including NGOs and faith-basedorganizations, in the delivery of health careto rural and disadvantaged populations(including the prevention, care, and treatmentof HIV/AIDS.OUTCOME INDICATORS1999 2003 2007#REPORTING % TARGET#REPORTING % TARGETNo. of countries with NGOs involved in medicines supply na na na 29/64 45% na
- Page 42 and 43: WHO MEDICINES STRATEGY 2004-2007 |
- Page 44 and 45: WHO MEDICINES STRATEGY 2004-2007 |
- Page 46 and 47: WHO MEDICINES STRATEGY 2004-2007 |
- Page 48 and 49: WHO MEDICINES STRATEGY 2004-2007 |
- Page 50 and 51: WHO MEDICINES STRATEGY 2004-2007 |
- Page 52 and 53: WHO MEDICINES STRATEGY 2004-2007 |
- Page 54 and 55: WHO MEDICINES STRATEGY 2004-2007 |
- Page 56 and 57: WHO MEDICINES STRATEGY 2004-2007 |
- Page 58 and 59: WHO MEDICINES STRATEGY 2004-2007 |
- Page 60 and 61: WHO MEDICINES STRATEGY 2004-2007 |
- Page 62 and 63: WHO MEDICINES STRATEGY 2004-2007 |
- Page 64 and 65: WHO MEDICINES STRATEGY 2004-2007 |
- Page 66 and 67: WHO MEDICINES STRATEGY 2004-2007 |
- Page 68 and 69: WHO MEDICINES STRATEGY 2004-2007 |
- Page 70 and 71: WHO MEDICINES STRATEGY 2004-2007 |
- Page 72 and 73: WHO MEDICINES STRATEGY 2004-2007 |
- Page 74 and 75: WHO MEDICINES STRATEGY 2004-2007 |
- Page 76 and 77: WHO MEDICINES STRATEGY 2004-2007 |
- Page 78 and 79: WHO MEDICINES STRATEGY 2004-2007 |
- Page 80 and 81: WHO MEDICINES STRATEGY 2004-2007 |
- Page 82 and 83: WHO MEDICINES STRATEGY 2004-2007 |
- Page 84 and 85: WHO MEDICINES STRATEGY 2004-2007 |
- Page 86 and 87: WHO MEDICINES STRATEGY 2004-2007 |
- Page 88 and 89: WHO MEDICINES STRATEGY 2004-2007 |
- Page 90 and 91: WHO MEDICINES STRATEGY 2004-2007 |
- Page 94 and 95: WHO MEDICINES STRATEGY 2004-2007 |
- Page 96 and 97: WHO MEDICINES STRATEGY 2004-2007 |
- Page 98 and 99: WHO MEDICINES STRATEGY 2004-2007 |
- Page 100 and 101: WHO MEDICINES STRATEGY 2004-2007 |
- Page 102 and 103: WHO MEDICINES STRATEGY 2004-2007 |
- Page 104 and 105: WHO MEDICINES STRATEGY 2004-2007 |
- Page 106 and 107: WHO MEDICINES STRATEGY 2004-2007 |
- Page 108 and 109: WHO MEDICINES STRATEGY 2004-2007 |
- Page 110 and 111: WHO MEDICINES STRATEGY 2004-2007 |
- Page 112 and 113: WHO MEDICINES STRATEGY 2004-2007 |
- Page 114 and 115: WHO MEDICINES STRATEGY 2004-2007 |
- Page 116 and 117: WHO MEDICINES STRATEGY 2004-2007 |
- Page 118 and 119: WHO MEDICINES STRATEGY 2004-2007 |
- Page 120 and 121: WHO MEDICINES STRATEGY 2004-2007 |
- Page 122 and 123: WHO MEDICINES STRATEGY 2004-2007 |
- Page 124 and 125: WHO MEDICINES STRATEGY 2004-2007 |
- Page 126 and 127: WHO MEDICINES STRATEGY 2004-2007 |
- Page 128 and 129: WHO MEDICINES STRATEGY 2004-2007 |
- Page 130 and 131: WHO MEDICINES STRATEGY 2004-2007 |
- Page 132 and 133: WHO MEDICINES STRATEGY 2004-2007 |
- Page 134 and 135: WHO MEDICINES STRATEGY 2004-2007 |
- Page 136 and 137: WHO MEDICINES STRATEGY 2004-2007 |
- Page 138 and 139: WHO MEDICINES STRATEGY 2004-2007 |
- Page 140 and 141: WHO MEDICINES STRATEGY 2004-2007 |
COMPONENTS OF THE STRATEGY | 81Meeting the challenges 2004-2007Over the next four years WHO will:> work with public-<strong>int</strong>erest NGOs, faith-basedorganizations, and countries to support theassessment of best practices within NGOs andfaith-based organizations for incorporation<strong>int</strong>o national <strong>medicines</strong> supply policies andstrategies.Challenges remainingMany governments do not fully recognize oracknowledge the important contribution thatNGOs and faith-based organizations could makeand are already making in the equitable deliveryof basic health care. Many good examples ofcost-effective drug supply management by NGOsand faith-based organizations are ignored and notused to their full potential as examples for publicservices.> support the NGOs and faith-basedorganizations by offering them a full shareof available technical information, policyguidance, and training opportunities.> continue to promote the use of all availablechannels, including NGOs and faith-basedorganizations, in the delivery of health careto rural and disadvantaged populations(including the prevention, care, and treatmentof HIV/AIDS.OUTCOME INDICATORS1999 2003 2007#REPORTING % TARGET#REPORTING % TARGETNo. of countries with NGOs involved in <strong>medicines</strong> supply na na na 29/64 45% na
Change language